Policy: An intergovernmental panel on antimicrobial resistance

Nature. 2014 May 29;509(7502):555-7. doi: 10.1038/509555a.
No abstract available

MeSH terms

  • Advisory Committees / organization & administration*
  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / supply & distribution*
  • Anti-Bacterial Agents / therapeutic use
  • Drug Discovery / organization & administration*
  • Drug Discovery / statistics & numerical data
  • Drug Discovery / trends
  • Drug Resistance, Microbial* / drug effects
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Epidemiological Monitoring
  • Global Health / statistics & numerical data
  • Goals
  • Health Policy* / economics
  • Health Policy* / trends
  • Humans
  • Inappropriate Prescribing / prevention & control
  • Inappropriate Prescribing / veterinary
  • International Cooperation*
  • Leadership
  • Methicillin-Resistant Staphylococcus aureus
  • United States
  • United States Food and Drug Administration
  • World Health Organization

Substances

  • Anti-Bacterial Agents